臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 51934041 Online Users : 941 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library

Scope

Adv. Search

Login

Administrator

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jen chang ko"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 271-280 of 290 (29 Page(s) Totally)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-03-11T07:58:30Z	Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis	Lee M.-R.; Huang Y.-P.; Kuo Y.-T.; Luo C.-H.; Shih Y.-J.; Shu C.-C.; Wang J.-Y.; JEN-CHANG KO; Yu C.-J.; Lin H.-H.
臺大學術典藏	2021-03-11T07:58:30Z	Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan	Chang C.-H.; Lee C.-H.; JEN-CHANG KO; Chang L.-Y.; Lee M.-C.; Wang J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-11T07:58:29Z	Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study	Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Yu C.-J.
臺大學術典藏	2021-03-11T07:58:29Z	Cementing an unwanted relationship	Chang C.-H.; Keng L.-T.; JEN-CHANG KO
臺大學術典藏	2021-03-11T07:58:29Z	Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan	Lee M.-R.; Ho C.-M.; Lee C.-H.; Lee M.-C.; Chang L.-Y.; Yu K.-L.; JEN-CHANG KO; Wang J.-Y.; Wang J.-T.; Lee L.-N.
臺大學術典藏	2021-03-11T07:58:28Z	Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells	Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏	2021-03-11T07:58:28Z	Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study	Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏	2021-03-11T07:58:28Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T07:58:27Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.; Yu K.-L.; Kuo H.-Y.; Liu T.-H.; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-03-11T07:58:27Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.; JEN-CHANG KO; Yang J.C.-H.; Shih J.-Y.

Showing items 271-280 of 290 (29 Page(s) Totally)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
View [10|25|50] records per page